All episodes
The Business of Aging and Three Reasons Why the FDA Drug Approval Rate Is So High
New York Genome Center’s Nathan Pearson on Public Outreach for Genomics
Tim Triche on Using Arrays for Cancer Research
Thermo’s Chris Linthwaite on Sequencing the Ebola Virus and the Future of Public Health
A Tool to Strengthen the Voice of Science in Online Journalism
Father of Child with Rare Disease Says Science Equals Medicine
Bina CEO Details Secret to Success in NGS Informatics
Cancer Researcher Tim Triche on the Staying Power of Microarrays
Want Answers? Look to the Non-Coding Region of the Genome, Says Cancer Researcher, Tim Triche
Ivan Oransky on Today's Retraction Boom
Genomics-Palooza, Diagnostics Fraud, and Biblical Prophets on the Future of Biotech
Ethical Issues around Editing Human Germline for the Future. Today It's about Plants and Animals, Says NYU's Art Caplan
We Got Research, PCSK9 Inhibitors, and Clinical Trials for Religion
The Multi-Platform Approach to Clinical Sequencing with Bobby Sebra, Icahn School
So That Happened, The Mad Genius, and Selling SynBio
Summer Genomics Festival, the Other Sports Genes, and Brain Surgery for Fruit Flies
The Sports Genes with Jeremy Koenig, Athletigen
Woodstock for Genomics? Richard Lumb and Carl Smith on this Month’s Festival
Geneticists Anonymous, the Sad State of Science Journalism, and New Kids on the Helix
The 9 Billion People Problem: Rod Wing on Plant Genomics
Should We Hold Back the Reins on Biotechnology? with Chris Gunter
Are We Ready to Trust Liquid Biopsies? with Milena Cankovic, Henry Ford Hospital
Gene and Tonic: Boxing for Cancer, Dubious Correlations, and When Should a Researcher Retire
New Patient Focused Genome Magazine Signing up Many Doctors Too
Gene and Tonic: The Decline of Pseudoscience, An Atheist for President, and What to Do with a Sexist Reviewer
Gene and Tonic: Sexism in Science, How to Spend an NIH Budget Increase, How Not to Spend It
Participation in Genomics Research a 21st Century Public Good, Says Paul Billings of Omicia
Gene and Tonic: Competition for 23andMe, Four Tips for Attending AACR 2015, and "Swab Stories"
Improving the Backbone of Clinical Genomics : Valerie Schneider, NCBI
Gene and Tonic: The ACA Turns Five, Ten Reasons to Have Your Genome Sequenced, and Humbled by the Ancients
Behind the Sequencing Bench with Dale Yuzuki
Gene and Tonic: The Tenth Commandment of Science, Icelandic Treasure, and TechBio Babies
It’s Pretty Bad: Andy Brooks of RUCDR on Sample Quality
Knowing More about What We Don’t Know: John McPherson on Cancer Genomics
Gene and Tonic: The iWatch and Research Kit, 23andMe Goes for the Big Time, No Spaceship
In Partnership with IBM’s Watson, Pathway Genomics Reinvents Itself
Affymetrix CEO, Frank Witney, on Arrays in the Age of Sequencing
Gene & Tonic: Disruption in Sequencing, Scientist Politicians, Some Cool Synbio
Changing the World with Color Changing Flowers
Cancer Researcher at Mayo Says Illumina Platform Maxing Out, Looks to BGI/Complete
Returning to Old Biotech Model, OncoMed Boasts of Seven Drugs in Clinical Trials by Mid 2015
Cutting through the Hype in Healthcare Innovation with David Shaywitz and Lisa Suennen
A Call to Consumers to Lead the Shift in Healthcare: Sharon Terry, Genetic Alliance
In Autoimmune Disease, Finding Clarity Beyond the Genome: Stefan Muellner, Protagen
Myriad Settlements Mark End of an Era: Antoinette Konski on Gene Patents
David Schwartz on the Future of Sequencing
Not a Stenographer to Power: Luke Timmerman and the New 'Timmerman Report'
FDA Will Take Time to Digest Comments on LDT Guidance, Says Liz Mansfield
Future of Personalized Medicine at Stake, says Amy Miller of PMC about LDT Regulation
'A Good Year' with John LaMattina
An Exciting Time for Mass Spec: Paul Beresford, Biodesix
Current Version of LDT Draft Guidance Means Much Fewer and Lower Quality Tests for Patients, Says Elaine Lyon of ARUP
The Sad State of Biospecimen Science with David Rimm, Yale
Cancer 2014: The Year in Review with Anna Barker
Faces of Leadership in Diagnostics: Surbhi Sarna
Historic Consensus Reached on Biospecimen Standards: Carolyn Compton, NBDA
Setting Better Expectations for Genomic Medicine: Geoff Ginsburg, Duke University
Test Driving Genomic Medicine: Thomas Quertermous, Stanford
The Silicon Valley Fantasy Trip: Sci-fi Author Kim Stanley Robinson Talks Life Science
Faces of Leadership in Diagnostics: Mara Aspinall
The Daunting Task of Managing Biospecimens at the World's Largest CRO: Diane Farhi, Quintiles
Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials
Biosampling Basics with Scott Jewell, Van Andel Institute
Faces of Leadership in Diagnostics: Bonnie Anderson, Veracyte
Biotech’s Gentleman Lawyer: Alan Mendelson
The Open Secret about the HER2 Assay with Jim Vaught
What a Physicist Can Tell Us about Cancer
'Moving Target Science:' Jonathan Brody on Pancreatic Cancer
The Progress of Clinical Genomics in Sweden with Ulf Gyllensten
Proteins Are Where It's At: Chip Petricoin, George Mason University
After a Decade on the Sidelines, Gene Myers Back into Sequencing, Excited about Long Reads
The Story of Aubrey de Grey and How the Study of Aging Became Mainstream
#ScienceHack with Connor Dickie, Synbiota
What Translational Gap? Michael Pishvaian on Advances in Tumor Profiling
A Dangerous Book? Science Historian Nathaniel Comfort Discusses “A Troublesome Inheritance”
Eric Schadt on Long Read Sequencing and Clinical Genomics
George Church at 60
Major Sequencing Projects Should Be Done with Long Reads, Says Dan Geraghty
Test Driving Illumina's X Ten with Shawn Baker, AllSeq
Short Read Sequencing Not Up to the Task of Characterizing Transcriptome Says Mike Snyder of Stanford
U.K. Life Science Update with Eliot Forster, MedCity
Paperwork, Not Algorithms the Biggest Challenge for Large Bioinformatics Projects, Says David Haussler, UCSC
Big Pharma Does Some Farming: Pearl Huang, GSK